About Ambani Organics
Ambani Organics is a publicly listed company based in Mumbai (India) founded in 1991. Dyes and chemicals are manufactured and supplied for industrial use. Its chief executive, as recorded, is Rakesh Shah. Its Indian entity Ambani Orgochem Limited reported revenue of ₹244 Cr. Its focus areas include Chemicals and Materials, Diversified Chemicals and Chemical Explosives.
Company details
Ambani Organics was founded in 1991 in Mumbai, India, where dyes and chemicals are produced and distributed. Operations focus on serving sectors including textiles, carpets, adhesives, paper, paints, construction, and paint driers. Products are supplied to various industries requiring specialized chemical solutions, with the company maintaining a presence in the manufacturing domain through its online platform at ambaniorganics.com. Leadership is provided by CEO MD Rakesh Shah.
- Headquarters Mumbai, India
- Stage Public
- SectorsChemicals & Materials
- Email••••••••
- Phone•••• ••••
- Website ambaniorganics.com
- Social LinkedIn
- Legal Name Ambani Orgochem Ltd
- Market Cap₹156 Cr
AMBANIORGO-ST · NSE
- Share Price₹189.00
+4.62% today
- Revenue₹244 Cr
FY 2025-26 · +26.6% YoY
- EBITDA₹16.37 Cr
Margin 6.7%
- Net Profit₹1.34 Cr
FY 2025-26 · +6600.0% YoY
- P/E (TTM)112.0x
P/B 2.6x
Associated legal entities of Ambani Organics
Ambani Organics operates through Ambani Orgochem Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ambani Orgochem Limited Listed CIN L24220MH1985PLC036774 | Active | 08 Jul 1985 | Thane, Maharashtra | ₹244 Cr | 148 | 10 | View details |
Board of directors of Ambani Orgochem Limited (Ambani Organics)
Ambani Orgochem Limited is the primary company behind Ambani Organics. The board of Ambani Orgochem Limited currently have 7 directors; the longest-serving is Rakesh Hasmukhlal Shah, appointed in 1996. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rakesh Hasmukhlal Shah DIN 00503074 | Managing Director | 08 Mar 1996 | 30 yrs 8 mo | Ambani Orgochem Limited |
| Apooni Rakesh Shah DIN 00503116 | Whole-time director | 01 May 2002 | 24 yrs 6 mo | Ambani Orgochem Limited |
| Prakash Anna Mahanwar DIN 08100755 | Director | 02 Apr 2018 | 8 yrs 7 mo | Ambani Orgochem Limited |
| Bhavin Jitendra Patel DIN 10482169 | Director | 20 Feb 2024 | 2 yrs 8 mo | Ambani Orgochem Limited |
| Neerajkumar Amarjeet Pandey DIN 10495819 | Director | 20 Feb 2024 | 2 yrs 8 mo | Ambani Orgochem Limited |
| Rajesh Vasudeo Desai DIN 00007960 | Director | 04 Dec 2025 | 11 mo | Ambani Orgochem Limited |
| Mahesh Shrirang Jagdale DIN 11846617 | Director | 24 Jul 2026 | 3 mo | Ambani Orgochem Limited |
People of Ambani Organics
1 people are tracked at Ambani Organics (1 in leadership).
| Name | Role | Group |
|---|---|---|
| CEO & MD | Leadership |
Complete people profiles for Ambani Organics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Ambani Organics
Ambani Organics is a publicly listed company on the NSE with ticker symbol AMBANIORGO in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date18 Jul 2018
- Listed onNSE: AMBANIORGO
- Listed entityAmbani Orgochem Ltd
- Exchange sectorProcess industries
- ISININE00C501018
- Share price₹154.00 (+4.98% on the day) · 2026-10-14
- Market capitalisation₹131 Cr
- Price to earnings88.6
- EPS (diluted, trailing year)₹1.74
- Volume (last session)18,000
Financials of Ambani Organics
Exchange-reported figures of Ambani Orgochem Limited, the listed company behind Ambani Organics (NSE: AMBANIORGO-ST).
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 244 | 193 | 136 | 132 | 125 | 86.67 | 72.87 |
| Revenue growth | +26.6% | +41.4% | +3.2% | +5.6% | +44.2% | +18.9% | - |
| EBITDA | 16.37 | 4.35 | 2.08 | 7.91 | 6.42 | 5.91 | 5.17 |
| EBITDA margin | +6.7% | +2.3% | +1.5% | +6.0% | +5.1% | +6.8% | +7.1% |
| Profit before tax | 4.15 | 0.44 | 0.24 | 3.01 | 2.81 | 2.61 | 2.28 |
| Net profit | 1.34 | 0.02 | (1.66) | 2.00 | 2.06 | 1.66 | 1.47 |
| Net profit margin | +0.6% | +0.0% | -1.2% | +1.5% | +1.7% | +1.9% | +2.0% |
| EPS (₹) | 1.03 | (2.01) | 4.31 | 3.07 | 3.13 | 3.35 | 2.72 |
| Balance sheet | |||||||
| Total assets | - | 118 | 115 | 112 | 91.19 | 60.19 | 44.85 |
| Net worth | - | 56.88 | 52.03 | 37.66 | 36.36 | 18.53 | 16.83 |
| Total debt | - | 53.95 | 55.07 | 66.70 | 47.13 | 33.90 | 19.93 |
| Cash & bank | - | 16.22 | 7.11 | 5.88 | 10.59 | 3.11 | 2.59 |
| Net working capital | - | 33.34 | 45.73 | 43.85 | 51.96 | 39.39 | 29.01 |
| Cash flow | |||||||
| Cash from operations | - | 10.82 | (12.50) | 17.13 | (0.04) | (3.78) | 4.57 |
| Cash from investing | - | 1.53 | (0.70) | (38.10) | (19.97) | (5.92) | (3.50) |
| Cash from financing | - | (2.51) | 14.43 | 16.26 | 27.49 | 10.21 | (1.87) |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 244 | 193 | 136 | 132 | 125 | 86.67 | 72.87 |
| Revenue growth | +26.6% | +41.4% | +2.8% | +6.0% | +44.2% | +18.9% | - |
| EBITDA | 16.26 | 4.24 | 1.99 | 8.24 | 6.32 | 5.81 | 5.06 |
| EBITDA margin | +6.7% | +2.2% | +1.5% | +6.2% | +5.1% | +6.7% | +6.9% |
| Profit before tax | 4.08 | 0.37 | 0.19 | 2.94 | 2.75 | 2.55 | 2.21 |
| Net profit | 1.36 | (0.06) | (1.70) | 1.93 | 2.02 | 1.60 | 1.61 |
| Net profit margin | +0.6% | -0.0% | -1.3% | +1.5% | +1.6% | +1.9% | +2.2% |
| EPS (₹) | 1.06 | (2.09) | 3.29 | 2.96 | 3.06 | 3.20 | 2.99 |
| Balance sheet | |||||||
| Total assets | - | 118 | 115 | 91.40 | 91.36 | 60.41 | 45.13 |
| Net worth | - | 56.88 | 52.10 | 37.77 | 36.54 | 18.75 | 17.13 |
| Total debt | - | 53.94 | 55.07 | 45.88 | 47.12 | 33.89 | 19.92 |
| Cash & bank | - | 16.20 | 6.35 | 5.84 | 10.55 | 3.07 | 2.56 |
| Net working capital | - | 33.08 | 45.49 | 22.76 | 51.69 | 39.12 | 28.78 |
| Cash flow | |||||||
| Cash from operations | - | 10.82 | (12.48) | 22.77 | (7.32) | (3.79) | 4.57 |
| Cash from investing | - | 1.53 | (0.70) | (38.10) | (11.36) | (5.92) | (3.50) |
| Cash from financing | - | (2.51) | 14.43 | 10.62 | 26.16 | 10.21 | (1.87) |
Financial Statements
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 244 | 193 | 136 | 132 | 125 | 86.67 | 72.87 |
| Revenue growth | +26.6% | +41.4% | +3.2% | +5.6% | +44.2% | +18.9% | - |
| Other income | 0.00 | 6.99 | 7.82 | 0.74 | 1.06 | 0.75 | 0.51 |
| Total expenses | 227 | 188 | 134 | 124 | 119 | 80.76 | 67.70 |
| Employee cost | 0.00 | 6.93 | 6.95 | 3.09 | 3.10 | 2.37 | 1.93 |
| EBITDA | 16.37 | 4.35 | 2.08 | 7.91 | 6.42 | 5.91 | 5.17 |
| EBITDA margin | +6.7% | +2.3% | +1.5% | +6.0% | +5.1% | +6.8% | +7.1% |
| Depreciation | 3.81 | 3.08 | 2.83 | 1.46 | 1.41 | 1.03 | 0.82 |
| Interest | 8.41 | 7.82 | 6.83 | 4.18 | 3.26 | 3.02 | 2.58 |
| Profit before tax | 4.15 | 0.44 | 0.24 | 3.01 | 2.81 | 2.61 | 2.28 |
| Tax | 2.81 | 1.29 | (2.79) | 1.04 | 0.79 | 0.91 | 0.90 |
| Net profit | 1.34 | 0.02 | (1.66) | 2.00 | 2.06 | 1.66 | 1.47 |
| Net profit margin | +0.6% | +0.0% | -1.2% | +1.5% | +1.7% | +1.9% | +2.0% |
| EPS (₹) | 1.03 | (2.01) | 4.31 | 3.07 | 3.13 | 3.35 | 2.72 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | - | 13.35 | 12.75 | 12.12 | 12.12 | 5.08 | 5.08 |
| Reserves & surplus | - | 40.69 | 32.28 | 25.54 | 24.24 | 13.45 | 11.75 |
| Shareholders' funds (net worth) | - | 56.88 | 52.03 | 37.66 | 36.36 | 18.53 | 16.83 |
| Minority interest | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Secured loans | - | 52.97 | 55.06 | 62.22 | 47.12 | 33.08 | 19.00 |
| Unsecured loans | - | 0.98 | 0.01 | 4.48 | 0.01 | 0.82 | 0.93 |
| Total debt | - | 53.95 | 55.07 | 66.70 | 47.13 | 33.90 | 19.93 |
| Total liabilities | - | 118 | 115 | 112 | 91.19 | 60.19 | 44.85 |
| Assets | |||||||
| Gross block | - | 88.66 | 67.64 | 28.11 | 27.77 | 25.47 | 17.92 |
| Net block | - | 76.54 | 58.60 | 21.29 | 22.18 | 21.16 | 14.64 |
| Capital work in progress | - | 7.00 | 7.92 | 47.11 | 9.39 | 0.00 | 1.61 |
| Investments | - | 0.07 | 0.07 | 0.07 | 0.07 | 0.37 | 0.20 |
| Inventories | - | 41.27 | 29.18 | 22.98 | 21.35 | 17.78 | 16.58 |
| Sundry debtors | - | 42.40 | 26.74 | 28.13 | 32.03 | 30.08 | 23.36 |
| Cash & bank balances | - | 16.22 | 7.11 | 5.88 | 10.59 | 3.11 | 2.59 |
| Loans & advances | - | 22.99 | 43.37 | 10.45 | 7.62 | 5.14 | 3.37 |
| Total current assets | - | 123 | 106 | 67.44 | 71.59 | 56.11 | 45.90 |
| Total current liabilities | - | 89.54 | 60.67 | 23.59 | 19.63 | 16.72 | 16.89 |
| Net working capital | - | 33.34 | 45.73 | 43.85 | 51.96 | 39.39 | 29.01 |
| Total assets | - | 118 | 115 | 112 | 91.19 | 60.19 | 44.85 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | - | 6.38 | 5.88 | 10.59 | 3.11 | 2.59 | 3.39 |
| Net cash from operating activities | - | 10.82 | (12.50) | 17.13 | (0.04) | (3.78) | 4.57 |
| Net cash from investing activities | - | 1.53 | (0.70) | (38.10) | (19.97) | (5.92) | (3.50) |
| Net cash from financing activities | - | (2.51) | 14.43 | 16.26 | 27.49 | 10.21 | (1.87) |
| Net change in cash | - | 9.84 | 1.23 | (4.71) | 7.48 | 0.52 | (0.80) |
| Closing cash | - | 16.22 | 7.11 | 5.88 | 10.59 | 3.11 | 2.59 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +26.6% | +41.4% | +3.2% | +5.6% | +44.2% | +18.9% | - |
| EBITDA growth | +276.3% | +109.1% | -73.7% | +23.2% | +8.6% | +14.3% | - |
| PBT growth | +843.2% | +83.3% | -92.0% | +7.1% | +7.7% | +14.5% | -5.0% |
| Net income growth | +6600.0% | +101.2% | -183.0% | -2.9% | +24.1% | +12.9% | - |
| Revenue CAGR (3Y) | +22.7% | +15.5% | +16.3% | +21.9% | +16.2% | +9.9% | +11.7% |
| EBITDA CAGR (3Y) | +27.4% | -12.2% | -29.4% | +15.2% | +7.4% | +8.4% | +19.4% |
| Profitability & leverage | |||||||
| Net income margin | +0.6% | -0.4% | +2.2% | +1.5% | +1.6% | +2.0% | +1.9% |
| Return on capital employed | - | +6.7% | +2.3% | +7.1% | +8.0% | +10.7% | +12.0% |
| Return on net worth | - | -1.4% | -4.2% | +6.3% | +8.2% | +9.6% | +8.6% |
| Debt / equity | - | 1.00 | 1.13 | 1.54 | 1.48 | 1.52 | 1.07 |
| Long-term debt / equity | - | 0.41 | 0.52 | 0.48 | 0.32 | 0.23 | 0.12 |
| Interest cover | 66.96 | 615.75 | -910.67 | 64.81 | 65.07 | 61.89 | 59.31 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 2.46 | 3.31 | 5.41 | 5.37 | 4.53 | 5.01 |
| Inventory turnover | - | 5.47 | 6.08 | 6.82 | 7.31 | 5.72 | 5.03 |
| Debtors turnover | - | 5.57 | 5.78 | 5.03 | 4.61 | 3.67 | 3.69 |
| EPS (₹) | 1.03 | (2.01) | 4.31 | 3.07 | 3.13 | 3.35 | 2.72 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 63.12 | 55.73 | 49.70 | 47.69 | 36.49 | 33.14 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 244 | 193 | 136 | 132 | 125 | 86.67 | 72.87 |
| Revenue growth | +26.6% | +41.4% | +2.8% | +6.0% | +44.2% | +18.9% | - |
| Other income | 0.00 | 6.99 | 7.82 | 0.30 | 1.06 | 0.75 | 0.51 |
| Total expenses | 227 | 188 | 134 | 124 | 119 | 80.86 | 67.81 |
| Employee cost | 0.00 | 6.93 | 6.95 | 3.09 | 3.10 | 2.37 | 1.93 |
| EBITDA | 16.26 | 4.24 | 1.99 | 8.24 | 6.32 | 5.81 | 5.06 |
| EBITDA margin | +6.7% | +2.2% | +1.5% | +6.2% | +5.1% | +6.7% | +6.9% |
| Depreciation | 3.77 | 3.04 | 2.79 | 1.42 | 1.37 | 0.99 | 0.78 |
| Interest | 8.41 | 7.82 | 6.83 | 4.18 | 3.26 | 3.02 | 2.58 |
| Profit before tax | 4.08 | 0.37 | 0.19 | 2.94 | 2.75 | 2.55 | 2.21 |
| Tax | 2.72 | 1.28 | (2.81) | 1.04 | 0.77 | 0.91 | 0.70 |
| Net profit | 1.36 | (0.06) | (1.70) | 1.93 | 2.02 | 1.60 | 1.61 |
| Net profit margin | +0.6% | -0.0% | -1.3% | +1.5% | +1.6% | +1.9% | +2.2% |
| EPS (₹) | 1.06 | (2.09) | 3.29 | 2.96 | 3.06 | 3.20 | 2.99 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | - | 13.35 | 12.75 | 12.12 | 12.12 | 5.08 | 5.08 |
| Reserves & surplus | - | 40.69 | 32.35 | 25.65 | 24.42 | 13.67 | 12.05 |
| Shareholders' funds (net worth) | - | 56.88 | 52.10 | 37.77 | 36.54 | 18.75 | 17.13 |
| Secured loans | - | 52.97 | 54.99 | 41.41 | 47.12 | 33.08 | 19.00 |
| Unsecured loans | - | 0.97 | 0.08 | 4.47 | 0.00 | 0.81 | 0.92 |
| Total debt | - | 53.94 | 55.07 | 45.88 | 47.12 | 33.89 | 19.92 |
| Total liabilities | - | 118 | 115 | 91.40 | 91.36 | 60.41 | 45.13 |
| Assets | |||||||
| Gross block | - | 86.01 | 64.99 | 25.47 | 25.12 | 22.82 | 15.28 |
| Net block | - | 74.35 | 56.36 | 19.03 | 19.86 | 18.80 | 12.25 |
| Capital work in progress | - | 7.00 | 7.92 | 47.11 | 9.39 | 0.00 | 1.61 |
| Investments | - | 1.34 | 1.34 | 1.34 | 1.34 | 1.64 | 1.47 |
| Inventories | - | 41.27 | 29.18 | 22.98 | 21.35 | 17.78 | 16.58 |
| Sundry debtors | - | 42.22 | 26.56 | 27.94 | 31.85 | 29.90 | 23.18 |
| Cash & bank balances | - | 16.20 | 6.35 | 5.84 | 10.55 | 3.07 | 2.56 |
| Loans & advances | - | 22.90 | 44.04 | 10.38 | 7.56 | 5.07 | 3.31 |
| Total current assets | - | 123 | 106 | 67.14 | 71.31 | 55.82 | 45.63 |
| Total current liabilities | - | 89.51 | 60.64 | 44.38 | 19.62 | 16.70 | 16.85 |
| Net working capital | - | 33.08 | 45.49 | 22.76 | 51.69 | 39.12 | 28.78 |
| Total assets | - | 118 | 115 | 91.40 | 91.36 | 60.41 | 45.13 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | - | 6.35 | 5.84 | 10.55 | 3.07 | 2.56 | 3.36 |
| Net cash from operating activities | - | 10.82 | (12.48) | 22.77 | (7.32) | (3.79) | 4.57 |
| Net cash from investing activities | - | 1.53 | (0.70) | (38.10) | (11.36) | (5.92) | (3.50) |
| Net cash from financing activities | - | (2.51) | 14.43 | 10.62 | 26.16 | 10.21 | (1.87) |
| Net change in cash | - | 9.84 | 1.24 | (4.71) | 7.48 | 0.51 | (0.80) |
| Closing cash | - | 16.20 | 6.35 | 5.84 | 10.55 | 3.07 | 2.56 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +26.6% | +41.4% | +2.8% | +6.0% | +44.2% | +18.9% | - |
| EBITDA growth | +283.5% | +113.1% | -75.9% | +30.4% | +8.8% | +14.8% | - |
| PBT growth | +1002.7% | +94.7% | -93.5% | +6.9% | +7.8% | +15.4% | -10.5% |
| Net income growth | +2366.7% | +96.5% | -188.1% | -4.5% | +26.3% | -0.6% | - |
| Revenue CAGR (3Y) | +22.5% | +15.5% | +16.3% | +22.1% | +16.3% | +9.9% | +11.7% |
| EBITDA CAGR (3Y) | +25.4% | -12.5% | -30.0% | +17.7% | +6.6% | +7.0% | +18.1% |
| Profitability & leverage | |||||||
| Net income margin | +0.6% | -0.5% | +2.2% | +1.4% | +1.6% | +1.9% | +2.1% |
| Return on capital employed | - | +6.6% | +2.2% | +7.8% | +7.9% | +10.5% | +11.8% |
| Return on net worth | - | -1.5% | -6.1% | +6.1% | +7.9% | +9.1% | +9.3% |
| Debt / equity | - | 1.00 | 1.12 | 1.25 | 1.47 | 1.50 | 1.06 |
| Long-term debt / equity | - | 0.41 | 0.52 | 0.48 | 0.32 | 0.21 | 0.09 |
| Interest cover | 67.33 | 651.67 | -853.75 | 61.29 | 65.86 | 62.66 | 60.28 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 2.55 | 3.01 | 6.00 | 5.97 | 5.15 | 5.94 |
| Inventory turnover | - | 5.47 | 5.22 | 6.84 | 7.31 | 5.72 | 5.03 |
| Debtors turnover | - | 5.60 | 5.00 | 5.07 | 4.63 | 3.70 | 3.72 |
| EPS (₹) | 1.06 | (2.09) | 3.29 | 2.96 | 3.06 | 3.20 | 2.99 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 63.13 | 55.83 | 49.87 | 47.97 | 36.92 | 33.72 |
Top companies in Core & Diversified Chemicals
3 companies that operate in the same segment as Ambani Organics (Core & Diversified Chemicals) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of fertilizers, industrial chemicals, crop nutrition products, and real estate | 1979 | Pune, Maharashtra, India | USD 1.21 B | 1,020 | ||
Specialty chemicals are manufactured through integrated R&D and production processes. | 2023 | Bengaluru, Karnataka, India | USD 72.97 M | USD 23.86 M | ||
Manufactures coal tar and basic industrial chemicals. | 1987 | Kolkata, West Bengal, India | USD 24 M | USD 515.01 M | 1,161 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ambani Organics
Complete news archive for Ambani Organics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ambani Organics
Ambani Organics was founded in 1991.
Ambani Organics is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Rakesh Shah is the CEO of Ambani Organics, as recorded in our data.
The primary company behind Ambani Organics, Ambani Orgochem Limited, reported revenue of ₹244 Cr for FY 2026, up 27% year on year.
Ambani Organics was founded in 1991 in Mumbai, India, where dyes and chemicals are produced and distributed. Operations focus on serving sectors including textiles, carpets, adhesives, paper, paints, construction, and paint driers. Products are supplied to various industries requiring specialized chemical solutions, with the company maintaining a presence in the manufacturing domain through its online platform at ambaniorganics.com. Leadership is provided by CEO MD Rakesh Shah.
Yes, Ambani Organics is publicly traded on NSE under the ticker symbol AMBANIORGO.
Ambani Organics operates through Ambani Orgochem Limited.
The legal entities of Ambani Organics currently have 10 directors, including Prakash Anna Mahanwar, Apooni Rakesh Shah, Rakesh Hasmukhlal Shah and others.